• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

15,16-二氢丹参酮I对人肝癌细胞的抗增殖作用:通过细胞周期阻滞及对AMP激活的蛋白激酶/Akt/哺乳动物雷帕霉素靶蛋白和丝裂原活化蛋白激酶信号通路的调控

Anti-proliferative Effect of 15,16-Dihydrotanshinone I Through Cell Cycle Arrest and the Regulation of AMP-activated Protein Kinase/Akt/mTOR and Mitogen-activated Protein Kinase Signaling Pathway in Human Hepatocellular Carcinoma Cells.

作者信息

Hong Ji-Young, Park So Hyun, Park Hyen Joo, Lee Sang Kook

机构信息

College of Pharmacy, Seoul National University, Seoul, Korea.

出版信息

J Cancer Prev. 2018 Jun;23(2):63-69. doi: 10.15430/JCP.2018.23.2.63. Epub 2018 Jun 30.

DOI:10.15430/JCP.2018.23.2.63
PMID:30003065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6037209/
Abstract

BACKGROUND

15,16-dihydrotanshinone I (DHTS) is a natural abietane diterpenoid that is mainly found in the roots of Bunge (Labiatae). DHTS exhibits a potential anti-proliferative effect in various human cancer cells. However, the mechanisms of action of DHTS as an anti-cancer agent have not been fully elucidated. Therefore, the present study investigated the anti-cancer effect of DHTS in terms of cell cycle regulation and the regulation of the AMP-activated protein kinase (AMPK)/Akt/mTOR signaling pathway in SK-HEP-1 human hepatocellular carcinoma cells.

METHODS

The anti-proliferative effects of DHTS were evaluated by the sulforhodamine B assay in SK-HEP-1 cells. Cell cycle distribution was analyzed by flow cytometry. The elucidation of mechanisms of action such as the AMPK/AKT/mTOR and mitogen-activated protein kinase (MAPK) pathway was assessed by Western blot analysis.

RESULTS

DHTS showed a significant anti-proliferative activity against SK-HEP-1 cells. DHTS induced cell cycle arrest in the G0/G1 phase, which was mediated by downregulation of cyclin D1, cyclin A, cyclin E, CDK4, CDK2, c-Myc and p-Rb expression and with increased expression of the CDK inhibitor p21. DHTS also activated the AMPK signaling. In addition, DHTS downregulated the Akt/mTOR and MAPK signaling pathways.

CONCLUSIONS

Our results suggest that the anti-proliferative activity of DHTS might be associated with the induction of G0/G1 phase cell cycle arrest and regulation of AMPK/Akt/mTOR and MAPK signaling pathways in SK-HEP-1 cells.

摘要

背景

15,16 - 二氢丹参酮I(DHTS)是一种天然的松香烷二萜类化合物,主要存在于丹参(唇形科)的根部。DHTS在多种人类癌细胞中表现出潜在的抗增殖作用。然而,DHTS作为抗癌剂的作用机制尚未完全阐明。因此,本研究从细胞周期调控以及SK - HEP - 1人肝癌细胞中AMP激活蛋白激酶(AMPK)/Akt/mTOR信号通路的调控方面,研究了DHTS的抗癌作用。

方法

通过磺酰罗丹明B法评估DHTS对SK - HEP - 1细胞的抗增殖作用。采用流式细胞术分析细胞周期分布。通过蛋白质免疫印迹分析评估AMPK/AKT/mTOR和丝裂原活化蛋白激酶(MAPK)通路等作用机制的阐明情况。

结果

DHTS对SK - HEP - 1细胞显示出显著的抗增殖活性。DHTS诱导细胞周期停滞在G0/G1期,这是通过下调细胞周期蛋白D1、细胞周期蛋白A、细胞周期蛋白E、细胞周期蛋白依赖性激酶4(CDK4)、细胞周期蛋白依赖性激酶2(CDK2)、c - Myc和磷酸化视网膜母细胞瘤蛋白(p - Rb)的表达以及增加细胞周期蛋白依赖性激酶抑制剂p21的表达来介导的。DHTS还激活了AMPK信号通路。此外,DHTS下调了Akt/mTOR和MAPK信号通路。

结论

我们的结果表明,DHTS的抗增殖活性可能与诱导SK - HEP - 1细胞G0/G1期细胞周期停滞以及调控AMPK/Akt/mTOR和MAPK信号通路有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/f3166bd1a1f1/jcp-23-063f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/e11a194fa9ec/jcp-23-063f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/55c85cb23091/jcp-23-063f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/37b99b5e7cc3/jcp-23-063f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/749ae18b4146/jcp-23-063f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/60c239082dda/jcp-23-063f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/f3166bd1a1f1/jcp-23-063f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/e11a194fa9ec/jcp-23-063f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/55c85cb23091/jcp-23-063f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/37b99b5e7cc3/jcp-23-063f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/749ae18b4146/jcp-23-063f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/60c239082dda/jcp-23-063f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/268b/6037209/f3166bd1a1f1/jcp-23-063f6.jpg

相似文献

1
Anti-proliferative Effect of 15,16-Dihydrotanshinone I Through Cell Cycle Arrest and the Regulation of AMP-activated Protein Kinase/Akt/mTOR and Mitogen-activated Protein Kinase Signaling Pathway in Human Hepatocellular Carcinoma Cells.15,16-二氢丹参酮I对人肝癌细胞的抗增殖作用:通过细胞周期阻滞及对AMP激活的蛋白激酶/Akt/哺乳动物雷帕霉素靶蛋白和丝裂原活化蛋白激酶信号通路的调控
J Cancer Prev. 2018 Jun;23(2):63-69. doi: 10.15430/JCP.2018.23.2.63. Epub 2018 Jun 30.
2
Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.15,16-二氢丹参酮I通过诱导G1期阻滞和凋亡对乳腺腺癌的抗肿瘤潜力
Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. doi: 10.1016/j.bcp.2007.08.009. Epub 2007 Aug 11.
3
Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).淫羊藿苷C通过抑制丝裂原活化蛋白激酶激活以及增加细胞周期蛋白依赖性激酶抑制剂p21(Cip1)和p27(Kip1)的表达来阻滞肝癌SK-Hep-1细胞周期的分子机制。
Food Chem Toxicol. 2006 Feb;44(2):227-35. doi: 10.1016/j.fct.2005.07.003. Epub 2005 Aug 19.
4
Dihydrotanshinone I inhibits the translational expression of hypoxia-inducible factor-1α.二氢丹参酮 I 抑制低氧诱导因子-1α 的翻译表达。
Chem Biol Interact. 2015 Oct 5;240:48-58. doi: 10.1016/j.cbi.2015.08.006. Epub 2015 Aug 14.
5
Antitumor Effect of Morusin via G1 Arrest and Antiglycolysis by AMPK Activation in Hepatocellular Cancer.桑辛素通过激活 AMPK 抑制糖酵解和 G1 期阻滞诱导肝癌细胞凋亡
Int J Mol Sci. 2021 Sep 30;22(19):10619. doi: 10.3390/ijms221910619.
6
15,16-Dihydrotanshinone I from the Functional Food Salvia miltiorrhiza Exhibits Anticancer Activity in Human HL-60 Leukemia Cells: in Vitro and in Vivo Studies.功能性食品丹参中的15,16-二氢丹参酮I在人HL-60白血病细胞中显示出抗癌活性:体外和体内研究
Int J Mol Sci. 2015 Aug 17;16(8):19387-400. doi: 10.3390/ijms160819387.
7
Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway.通关藤提取物通过抑制丝裂原活化蛋白激酶(MAPK)信号通路诱导人食管癌细胞G0/G1期细胞周期阻滞。
Chin J Nat Med. 2015 Jun;13(6):428-37. doi: 10.1016/S1875-5364(15)30036-4.
8
Adenine inhibits growth of hepatocellular carcinoma cells via AMPK-mediated S phase arrest and apoptotic cascade.腺嘌呤通过 AMPK 介导的 S 期阻滞和凋亡级联抑制肝癌细胞的生长。
Int J Med Sci. 2020 Feb 24;17(5):678-684. doi: 10.7150/ijms.42086. eCollection 2020.
9
15,16-Dihydrotanshinone I, a Compound of Salvia miltiorrhiza Bunge, Induces Apoptosis through Inducing Endoplasmic Reticular Stress in Human Prostate Carcinoma Cells.15,16-二氢丹参酮 I,丹参的一种化合物,通过诱导内质网应激诱导人前列腺癌细胞凋亡。
Evid Based Complement Alternat Med. 2011;2011:865435. doi: 10.1155/2011/865435. Epub 2011 Jan 13.
10
Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.白头翁酸 B 通过抑制多种致癌信号通路对人肝癌细胞表现出抗癌活性。
Phytomedicine. 2019 Jun;59:152759. doi: 10.1016/j.phymed.2018.11.019. Epub 2018 Nov 19.

引用本文的文献

1
Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure.优化型新生脉散对cAMP/Rap1A信号通路的调控减轻心力衰竭中的心肌纤维化
Chin Med. 2024 Feb 24;19(1):30. doi: 10.1186/s13020-024-00902-4.
2
Antiproliferative Activity of Gibbosic Acid H through Induction of G/G Cell Cycle Arrest and Apoptosis in Human Lung Cancer Cells.赤霉素H通过诱导人肺癌细胞G/G期细胞周期阻滞和凋亡发挥抗增殖活性。
J Cancer Prev. 2023 Dec 30;28(4):201-211. doi: 10.15430/JCP.2023.28.4.201.
3
Molecular Mechanism of Tanshinone against Prostate Cancer.

本文引用的文献

1
15,16-dihydrotanshinone I Induces Apoptosis and Inhibits the Proliferation, Migration of Human Osteosarcoma Cell Line 143B in vitro.15,16-二氢丹参酮I体外诱导人骨肉瘤细胞系143B凋亡并抑制其增殖和迁移。
Anticancer Agents Med Chem. 2017;17(9):1234-1242. doi: 10.2174/1871520615666151019092919.
2
15,16-Dihydrotanshinone I from the Functional Food Salvia miltiorrhiza Exhibits Anticancer Activity in Human HL-60 Leukemia Cells: in Vitro and in Vivo Studies.功能性食品丹参中的15,16-二氢丹参酮I在人HL-60白血病细胞中显示出抗癌活性:体外和体内研究
Int J Mol Sci. 2015 Aug 17;16(8):19387-400. doi: 10.3390/ijms160819387.
3
丹参酮防治前列腺癌的分子机制。
Molecules. 2022 Aug 30;27(17):5594. doi: 10.3390/molecules27175594.
4
Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells.二氢丹参酮-I 调节上皮间质转化(EMT),从而损害三阴性乳腺癌细胞的迁移和克隆形成能力。
Asian Pac J Cancer Prev. 2021 Jul 1;22(7):2177-2184. doi: 10.31557/APJCP.2021.22.7.2177.
5
Novel Oxovanadium Complex VO(hntdtsc)(NPIP): Anticancer Activity and Mechanism of Action on HeLa Cells.新型氧钒配合物VO(hntdtsc)(NPIP):对HeLa细胞的抗癌活性及作用机制
Front Pharmacol. 2021 Feb 8;11:608218. doi: 10.3389/fphar.2020.608218. eCollection 2020.
6
The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients.丹参酮的抗癌特性及其活性成分的药理作用。
Front Pharmacol. 2020 Mar 19;11:193. doi: 10.3389/fphar.2020.00193. eCollection 2020.
7
BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.BEZ235通过抑制PI3K/AKT/mTOR信号通路增强索拉非尼对肝癌细胞的抑制作用。
Am J Transl Res. 2019 Sep 15;11(9):5573-5585. eCollection 2019.
Hepatocellular carcinoma: Where there is unmet need.
肝细胞癌:存在未满足的需求之处。
Mol Oncol. 2015 Oct;9(8):1501-9. doi: 10.1016/j.molonc.2015.06.005. Epub 2015 Jun 25.
4
Targeting AMPK for cancer prevention and treatment.以AMPK为靶点进行癌症预防和治疗。
Oncotarget. 2015 Apr 10;6(10):7365-78. doi: 10.18632/oncotarget.3629.
5
Computational Identification and Systematic Classification of Novel Cytochrome P450 Genes in Salvia miltiorrhiza.丹参中新细胞色素P450基因的计算鉴定与系统分类
PLoS One. 2014 Dec 10;9(12):e115149. doi: 10.1371/journal.pone.0115149. eCollection 2014.
6
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
7
The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.腺苷酸活化蛋白激酶(AMPK)与癌症:代谢调控因子的多面性。
Cancer Lett. 2015 Jan 28;356(2 Pt A):165-70. doi: 10.1016/j.canlet.2014.01.018. Epub 2014 Jan 28.
8
Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial.舒尼替尼与索拉非尼治疗晚期肝细胞癌的随机对照 III 期临床试验结果。
J Clin Oncol. 2013 Nov 10;31(32):4067-75. doi: 10.1200/JCO.2012.45.8372. Epub 2013 Sep 30.
9
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.Brivanib 用于索拉非尼不耐受或治疗失败的晚期肝细胞癌患者:BRISK-PS 研究的随机 III 期结果。
J Clin Oncol. 2013 Oct 1;31(28):3509-16. doi: 10.1200/JCO.2012.47.3009. Epub 2013 Aug 26.
10
Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.AMPK 激活的预后意义和二甲双胍在肝细胞癌中的治疗效果。
Clin Cancer Res. 2013 Oct 1;19(19):5372-80. doi: 10.1158/1078-0432.CCR-13-0203. Epub 2013 Aug 13.